B. Tsang

Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan‐class I PI3K inhibitor, buparlisib

A. Roccaro, A. Sacco, A. Azab, 2014, American journal of hematology.

Distinct roles of class I PI3K isoforms in multiple myeloma cell survival and dissemination

A. Sacco, F. Azab, P. Maiso, 2014, Blood Cancer Journal.